Biogen sells equity stake in its biosimilar JV with Samsung Biologics for US $ 2.3 billion
The companies will continue with their exclusive agreements, including commercialization of their current portfolio
The companies will continue with their exclusive agreements, including commercialization of their current portfolio
The award was given as a result of NASSCOM's meticulous screening process, in which over 700 start-ups were shortlisted as the most promising companies of the year
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended December 31, 2021
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
Direct to consumer pharmacy and formation as pharmacy benefit manager further mission to drastically expand access to affordable pharmaceuticals
It meets stringent requirements for ensuring the safe storage and efficacy of temperature-sensitive vaccines, including those for Covid-19
Antibiotics mixed in wastewater often get disposed of into the water bodies resulting in wider antimicrobial resistance cases
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
Urges them to focus on tele-consultation like eSanjeevani and efficient monitoring of those in home isolation
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
Subscribe To Our Newsletter & Stay Updated